Signaling pathways and intervention for therapy of type 2 diabetes mellitus
Abstract Type 2 diabetes mellitus (T2DM) represents one of the fastest growing epidemic metabolic disorders worldwide and is a strong contributor for a broad range of comorbidities, including vascular, visual, neurological, kidney, and liver diseases. Moreover, recent data suggest a mutual interplay...
Main Authors: | Rong Cao, Huimin Tian, Yu Zhang, Geng Liu, Haixia Xu, Guocheng Rao, Yan Tian, Xianghui Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-06-01
|
Series: | MedComm |
Subjects: | |
Online Access: | https://doi.org/10.1002/mco2.283 |
Similar Items
-
Mitophagy: A potential therapeutic target for insulin resistance
by: Peng Ning, et al.
Published: (2022-08-01) -
Unraveling the Link between Ιnsulin Resistance and Bronchial Asthma
by: Konstantinos Bartziokas, et al.
Published: (2024-02-01) -
An Overview of Microparticulate Drug Delivery System and its ExtensiveTherapeutic Applications in Diabetes
by: Mona Hassan Rafiee, et al.
Published: (2022-08-01) -
А new drug in the complex therapy of diabetes mellitus. Post-registration experience in patients with type 1 and type 2 diabetes mellitus
by: S. V. Vorob'yev, et al.
Published: (2018-09-01) -
Anti-diabetic effect of aloin via JNK-IRS1/PI3K pathways and regulation of gut microbiota
by: Ruting Zhong, et al.
Published: (2022-01-01)